Balance Labs, Inc.
BLNC
$0.2122
$0.029115.89%
| Weiss Ratings | BLNC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | BLNC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Very Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Very Weak | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | BLNC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.25 | |||
| Price History | BLNC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -0.02% | |||
| 30-Day Total Return | -0.02% | |||
| 60-Day Total Return | 15.92% | |||
| 90-Day Total Return | 16.62% | |||
| Year to Date Total Return | -0.02% | |||
| 1-Year Total Return | -7.72% | |||
| 2-Year Total Return | -9.68% | |||
| 3-Year Total Return | -75.32% | |||
| 5-Year Total Return | -71.70% | |||
| 52-Week High % Change | -46.94% | |||
| 52-Week Low % Change | 16.62% | |||
| Price | BLNC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.40 | |||
| 52-Week Low Price | $0.18 | |||
| 52-Week Low Price (Date) | Aug 12, 2024 | |||
| 52-Week High Price (Date) | May 14, 2024 | |||
| Valuation | BLNC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 4.60M | |||
| Enterprise Value | 7.00M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.03 | |||
| Earnings Per Share Growth | 7.51% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -0.93 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.21 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -33.06 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | BLNC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 21.67M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | BLNC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 305 907 7600 | |||
| Address | 407 Lincoln Road Miami Beach, FL 33139 | |||
| Website | www.balancelabs.co | |||
| Country | United States | |||
| Year Founded | 2014 | |||
| Profitability | BLNC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | BLNC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -60.89% | |||
| Return on Equity | -- | |||
| Income Statement | BLNC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -152.10K | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -211.70K | |||
| Net Income (TTM) | -539.20K | |||
| Net Income Avl. to Common (TTM) | -539.20K | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -180.64% | |||
| EPS Diluted (TTM) | -0.03 | |||
| EPS Diluted Growth (Q YOY) | -178.13% | |||
| Balance Sheet | BLNC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 110.30K | |||
| Cash Per Share (Q) | $0.01 | |||
| Total Current Assets (Q) | 110.30K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -4.95M | |||
| Current Ratio (Q) | 0.022 | |||
| Book Value Per Share (Q) | -$0.23 | |||
| Total Assets (Q) | 110.30K | |||
| Total Current Liabilities (Q) | 5.06M | |||
| Total Debt (Q) | 2.51M | |||
| Total Liabilities (Q) | 5.06M | |||
| Total Common Equity (Q) | -4.95M | |||
| Cash Flow | BLNC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | 30.00K | |||
| Net Change in Cash (TTM) | -115.20K | |||
| Levered Free Cash Flow (TTM) | 19.90K | |||
| Cash from Operations (TTM) | -145.20K | |||
